News

The EU ​“One Substance One Assessment” (OSOA) package was published in the Official Journal on 12 December 2025 and entered into force on 1 January 2026.

IFRA and IOFI have published the 2025 edition of the IFRA-IOFI Labelling Manual, prepared by the joint GHS Task Force. The Manual was released on 15 January.

Fragrance value chain professionals gain practical guidance on Nagoya Protocol compliance and the emerging Cali Fund framework

IFRA Asia Pacific engages with the Singapore Chemical Industry Council to advance regulatory dialogue and regional cooperation

A visit to IFRA member company IFF’s Tilburg site highlighted how innovation, sustainability, and EU chemicals policy connect on the factory floor. The discussions focused on the practical impact of Omnibus VI on Europe’s fragrance industry and competitiveness.

“Sustainable Perfumery: The Art of Crafting Fragrances and Nurturing Careers” commenced in December 2025 at Hindu College, following the successful completion of Batch One, where all participants were successfully placed within the fragrance industry.

On 3 February, participants of a Breakfast Event at the European Parliament in Brussels discussed the future of the EU cosmetics and fragrance sectors in the context of the Omnibus VI package on chemicals.

Today in Antwerp, IFRA attended the third European Industry Summit, where policymakers and industry representatives reviewed Europe’s industrial competitiveness and the implementation of the Antwerp Declaration.

Matthias Vey, Vice President of Scientific Affairs for IFRA will be speaking at the IFRA UK Sensitisers Seminar, taking place in London on 7 May 2026.

The International Fragrance Association (IFRA) recently contributed to the ​“Safety Assessment of Cosmetic Products in the EU” course at the Vrije Universiteit Brussel (VUB), focusing on the practicalities of fragrance safety.

Geneva, 4 February 2026 – The International Fragrance Association (IFRA) has published its Annual Report 2025, marking a year defined by global connection, scientific progress and strengthened engagement with regulators, members and stakeholders worldwide.

A new studyin Regulatory Toxicology and Pharmacology confirms that three quantitative New Approach Methodologies (NAMs) – Regression model, SARA‑ICE, and GARDSkin – can generate reliable points of departure for skin‑sensitisation quantitative risk assessment evaluated using the IDEA Reference Chemical Potency List.